Expert Opinion on Pharmacotherapy, Volume 11, Issue 4 (2010)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 11, Issue 4 (2010)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Volume 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Original Research

Article
Extent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo-controlled trial
Edgar A Mueller MD PhD FCP, Wilhelm Kirch MD PhD & Susanne Reiter MD
Pages: 493-498
Published online: 17 Feb 2010
AbstractforExtent and time course of pain intensity upon treatment with a topical diclofenac sodium patch versus placebo in acute traumatic injury based on a validated end point: post hoc analysis of a randomized placebo-controlled trial | Full Text | References | PDF (205.5 KB)
  • 252 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination
Gemma Caterina Maria Rossi, Gian Maria Pasinetti, Luigia Scudeller, Carmine Tinelli, Giovanni Milano & Paolo Emilio Bianchi
Pages: 499-504
Published online: 17 Feb 2010
AbstractforMonitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination | Full Text | References | PDF (183.3 KB)
  • 155 Views
  • 12 CrossRef citations
  • 0Altmetric

Reviews

Article
Treatment of multiple sclerosis in children and adolescents
Nancy L Kuntz MD, Dorothee Chabas MD PhD, Bianca Weinstock-Guttman MD, Tanuja Chitnis MD, E Ann Yeh MD, Lauren Krupp MD, Jayne Ness MD PhD, Moses Rodriguez MD, Emmanuelle Waubant MD PhD & Network of US Pediatric Multiple Sclerosis Centers of Excellence
Pages: 505-520
Published online: 17 Feb 2010
AbstractforTreatment of multiple sclerosis in children and adolescents | Full Text | References | PDF (260.6 KB)
  • 465 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Differences in pharmacology and their translation into differences in clinical efficacy – a comparison of the renin angiotensin blocking agents irbesartan and losartan
Peter Bramlage & Christoph Schindler
Pages: 521-535
Published online: 23 Dec 2009
AbstractforDifferences in pharmacology and their translation into differences in clinical efficacy – a comparison of the renin angiotensin blocking agents irbesartan and losartan | Full Text | References | PDF (386.4 KB)
  • 401 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Pharmacological strategies against cold ischemia reperfusion injury
Mohamed Amine Zaouali, Hassen Ben Abdennebi, Susagna Padrissa-Altés, Asma Mahfoudh-Boussaid & Joan Roselló-Catafau
Pages: 537-555
Published online: 17 Feb 2010
AbstractforPharmacological strategies against cold ischemia reperfusion injury | Full Text | References | PDF (494.4 KB)
  • 404 Views
  • 52 CrossRef citations
  • 0Altmetric
Article
Cutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management
Mahreen Ameen MA MPH MRCP MD DTM & H
Pages: 557-569
Published online: 17 Feb 2010
AbstractforCutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management | Full Text | References | PDF (244.8 KB)
  • 222 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Treatment of chronic hepatitis C in elderly patients
Y Horsmans MD PhD
Pages: 571-577
Published online: 17 Feb 2010
AbstractforTreatment of chronic hepatitis C in elderly patients | Full Text | References | PDF (186 KB)
  • 111 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
State of the art: radiolabeled microspheres treatment for liver malignancies
Amélie Deleporte MD, Patrick Flamen MD PhD & Alain Hendlisz MD
Pages: 579-586
Published online: 17 Feb 2010
AbstractforState of the art: radiolabeled microspheres treatment for liver malignancies | Full Text | References | PDF (248.8 KB)
  • 353 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Acute promyelocytic leukemia: what are the treatment options?
Felicetto Ferrara MD
Pages: 587-596
Published online: 17 Feb 2010
AbstractforAcute promyelocytic leukemia: what are the treatment options? | Full Text | References | PDF (257.5 KB)
  • 247 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Pharmacotherapy of end-stage renal disease
Holger Schmid MD MSc, Helmut Schiffl MD & Stephan R Lederer MD
Pages: 597-613
Published online: 17 Feb 2010
AbstractforPharmacotherapy of end-stage renal disease | Full Text | References | PDF (268.8 KB)
  • 773 Views
  • 9 CrossRef citations
  • 0Altmetric

Drug Evaluations

Article
Daptomycin: pharmacology and clinical use
Christos Kosmidis MD & Donald P Levine MD
Pages: 615-625
Published online: 17 Feb 2010
AbstractforDaptomycin: pharmacology and clinical use | Full Text | References | PDF (259.9 KB)
  • 844 Views
  • 35 CrossRef citations
  • 0Altmetric
Article
Levodopa in Parkinson's disease: from the past to the future
Gianni Pezzoli MD & Michela Zini MD
Pages: 627-635
Published online: 17 Feb 2010
AbstractforLevodopa in Parkinson's disease: from the past to the future | Full Text | References | PDF (219.5 KB)
  • 1029 Views
  • 38 CrossRef citations
  • 0Altmetric
Article
Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders
Richard C Josiassen, Jessica Curtis, Dawn M Filmyer, Brett Audino, Nina Skuban & Rita A Shaughnessy
Pages: 637-648
Published online: 17 Feb 2010
AbstractforTolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders | Full Text | References | PDF (418.6 KB)
  • 191 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Rotigotine transdermal delivery for the treatment of restless legs syndrome
Friederike Sixel-Döring MD & Claudia Trenkwalder MD
Pages: 649-656
Published online: 17 Feb 2010
AbstractforRotigotine transdermal delivery for the treatment of restless legs syndrome | Full Text | References | PDF (239.5 KB)
  • 151 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Laromustine (cloretazine)
Norbert Vey & Frank Giles
Pages: 657-667
Published online: 17 Feb 2010
AbstractforLaromustine (cloretazine) | Full Text | References | PDF (256.2 KB)
  • 147 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Ertapenem
Blaise L Congeni MD
Pages: 669-672
Published online: 17 Feb 2010
AbstractforErtapenem | Full Text | References | PDF (166.6 KB)
  • 967 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Role of ribavirin in HCV treatment response: now and in the future
Mamta K Jain MD MPH & Cindy Zoellner PharmD
Pages: 673-683
Published online: 17 Feb 2010
AbstractforRole of ribavirin in HCV treatment response: now and in the future | Full Text | References | PDF (392.9 KB)
  • 218 Views
  • 21 CrossRef citations
  • 0Altmetric

Clinical Trial Evaluation

Article
Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial
Evaluation of Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51
Chee W Khoo MRCP & Gregory YH Lip MD FRCP
Pages: 685-687
Published online: 28 Jan 2010
AbstractforInsights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial | Full Text | References | PDF (157.8 KB)
  • 696 Views
  • 24 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
Rizwana Parveen et al.
Review Article | Published online: 28 May 2024
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M. Acuña et al.
Review Article | Published online: 28 May 2024
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
Krystyna Dobrowolska et al.
Review Article | Published online: 27 May 2024
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants
Ann Childress
Review Article | Published online: 27 May 2024
View all latest articles